Biostrap Wristband to power investigation of long term cardiovascular impacts of COVID-19

Biostrap health band

A new clinical study by Tulane University is teaming up with Biostrap to investigate the long term cardiovascular and behavioral impacts of Covid-19.

This new observational study aims at using the wearable Biostrap for health monitoring in COVID-19 positive individuals to monitor persistent symptoms and any potential long-term complications or cardiovascular and behavioral impacts from the disease.

Related reading:

How the Biostrap works

Participants will wear a Biostrap wristband device that captures high-fidelity, raw photoplethysmography (PPG) waveforms and collects important indicators of heart and mental health, including heart rate, heart rate variability, pulse points, oxygen saturation, and sleep patterns. Biostrap Sleep monitoring

Biometric data will be collected and participants will be alerted if any measurements are outside their normal range.

Researchers are recruiting 100 participants who were diagnosed with COVID-19. The study’s primary outcome measures include the detection of any major cardiovascular events such as arrhythmia occurrence or recurrence, congestive heart failure, myocardial infarction, cardiomyopathy, and ischemic stroke. 

Participants will also be monitored for any signs of atrial arrhythmia including atrial fibrillation, atrial flutter, and atrial tachycardia. This study is expected to run for a period of 12 months.

Biostrap’s new sleep and health tracker, Biostrap EVO is getting ready to be shipped to the general public starting this November. 

The Biostrap EVO is a personal health monitor that measures, analyzes, and provides actionable insights on Sleep quality, Recovery metrics, Nocturnal biometrics, and comprehensive analysis reports.Biostrap Recovery analytics

The EVO is IP68 and has a Raw waveform Optical sensor (IR and Red). This new wearable is currently priced at $249. 

Although the battery life between charges is only 2.5 days, Biostream health ad fitness tracker have been used extensively in several validation studies and has shown promising results when it comes to the accuracy of the readings and also detection of Afib (atrial fibrillation) as well as detection of obstructive hypertrophic cardiomyopathy.

Previous articleAmazon Halo Tone Analysis : A Beginner’s User Guide and review
Next articleBOSE ‘s next gen hearables could feature fatigue and drowsiness detection
Sudz Niel Kar
I am a technologist with years of experience with Apple and wearOS products, have a BS in Computer Science and an MBA specializing in emerging tech, and owned the popular site AppleToolBox. In my day job, I advise Fortune 500 companies with their digital transformation strategies and also consult with numerous digital health startups in an advisory capacity. I'm VERY interested in exploring the digital health and fitness-tech evolution and keeping a close eye on patents, FDA approvals, strategic partnerships, and developments happening in the wearables and digital health sector. When I'm not writing or presenting, I run with my Apple Watch Ultra or Samsung Galaxy Watch and closely monitor my HRV and other recovery metrics.

1 COMMENT

  1. Good luck. My biostrap cant last more than 6 hours without dying and the company is absent.. a small company that doesnt respond to support requests. Activity tracking is very basic but battery doesnt allow all day use. Very disappointed with what seemed like a promising product.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.